ArticleOncotarget2017

Preclinical pharmacodynamic evaluation of drug candidate SKLB-178 in the treatment of non-small cell lung cancer.

Lei Zhong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.